Results 61 to 70 of about 121,678 (291)

Is polycystic ovary syndrome a sexual conflict? A review [PDF]

, 2016
Several studies have attempted to explain the high overall prevalence of polycystic ovary syndrome among women worldwide (about 4-10%) despite its link to subfertile phenotypes. For this reason, it is considered an evolutionary paradox.
BRIGANTE, Giulia, CASARINI, Livio, SIMONI, Manuela   +2 more
core   +1 more source

Direct economic burden of mental health disorders associated with polycystic ovary syndrome: Systematic review and meta-analysis

eLife, 2023
Background: Polycystic ovary syndrome (PCOS) is the most common hormone disorder affecting about one in seven reproductive-aged women worldwide and approximately 6 million women in the United States (U.S.).
Surabhi Yadav, Olivia Delau, Adam J Bonner, Daniela Markovic, William Patterson, Sasha Ottey, Richard P Buyalos, Ricardo Azziz   +7 more
doaj   +1 more source

Endocannabinoid receptor blockade increases hepatocyte growth factor and reduces insulin levels in obese women with polycystic ovary syndrome [PDF]

, 2016
There is evidence from animal and in-vitro studies that activation of the endocannabinoid system (EC) through cannabinoid receptor 1 (CB-1) is associated with liver injury, inflammation and hepatocellular carcinoma.1 Data suggests endogenous cannabinoids
Ahmed, Lina, Atkin, Stephen L., Coady, Anne-Marie, Dakroury, Youssra, Elshewehy, Abeer M. M., Kilpatrick, Eric S., Sathyapalan, Thozhukat   +6 more
core   +1 more source

The mitochondrial DNA copy number and ovary‐related reproductive disorders: A bidirectional two‐sample Mendelian randomization study

International Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 112-120, April 2025.
Abstract Objective In the present study, a bidirectional two‐sample Mendelian randomization approach was utilized to explore potential causal relationships between mitochondrial DNA copy number (mtDNA‐CN) and ovary‐related reproductive disorders (ORRDs), including ovarian dysfunction, ovarian cyst, polycystic ovary syndrome (PCOS), premature ovarian ...
Ke Peng, Xiao Han, Congquan Wu, Qiaowen Lu, Shujun Gao   +4 more
wiley   +1 more source

Parathyroid localization [PDF]

, 1986
Twenty-nine consecutive patients with suspected primary hyperparathyroidism were examined preoperatively using ultrasound, sonographically guided fine needle aspiration, and aspirate immunostaining for PTH.
Borisch, B., Gutekunst, R., Hafermann, W., Kiffner, E., Löhrs, U., Scriba, Peter Christian, Thies, E., Valesky, A.   +7 more
core   +1 more source

The association between levonorgestrel intrauterine devices and female fertility compared to other contraceptive methods: A historical cohort study

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective This study aimed to investigate whether the use of levonorgestrel intrauterine devices (LNG‐IUD) is associated with an increased need for medically assisted reproductive (MAR) treatment compared to other contraceptive methods. Methods This register‐based historical cohort study included 733 875 Danish women aged 18–42 years between ...
Mette Peters Michaelsen, Laura Cæcilie Nielsen, Michelle Poulsen, Regitze Gyldenholm Skals, Søren Lundbye‐Christensen, Ulrik Schiøler Kesmodel   +5 more
wiley   +1 more source

Polycystic ovary syndrome [PDF]

, 2004
The document attached has been archived with permission from the editor of the Medical Journal of Australia. An external link to the publisher’s copy is included.Polycystic ovary syndrome (PCOS) affects 5-20% of women of reproductive age worldwide.
A Corbould, A Corbould, A Dokras, A Dunaif, A Dunaif, A Dunaif, A Dunaif, A Gambineri, AA Deeks, AA Deeks, AD Coviello, AE Joham, AJ Krentz, AM Goss, AY Chang, B Banaszewska, B Dilbaz, BA Gower, BA Swiglo, BC Fauser, BC Fauser, BO Yildiz, BO Yildiz, BO Yildiz, BO Yildiz, BO Yildiz, BW Donesky, C Battaglia, C Farquhar, C Formuso, C Kitzinger, C Siristatidis, C Villarroel, CA McHorney, CB Book, Centers for Disease Control and Prevention (CDC), CJ Carlson, CK Welt, CL Harrison, CL Harrison, CM Boomsma, CM Burt Solorzano, CM DeUgarte, CN Bairey Merz, CR McCartney, D Cibula, D Lizneva, D Rosenbaum, D Skubleny, DA Dumesic, DA Dumesic, DA Ehrmann, DM Liu, DS Kiddy, DW Polson, E Carmina, E Carmina, E Carmina, E Carmina, E Carmina, E Carvalho, E Dahlgren, E Diamanti-Kandarakis, E Diamanti-Kandarakis, E Diamanti-Kandarakis, E Lerchbaum, E Vanky, EJ van Zuuren, EO Talbott, F Alvarez-Blasco, F Fanelli, F Ramezani Tehrani, FJ Broekmans, FL Teixeira Filho, FR Day, FR Tehrani, G Chazenbalk, G Conway, G Daskalopoulos, G Guyatt, G Kosova, G Ladson, GG Gosman, GL Fraser, H Abu Hashim, H Mani, HF Escobar-Morreale, HJ Teede, HJ Teede, I Ek, I Souter, J Du, J Laitinen, J Schmidt, J Sun, J Zawadzki, JA Balfour, JA Visser, JA Visser, JE Nestler, JE Nestler, JL Cresswell, JM McAllister, JM Vink, JP Baillargeon, JS Laven, KA Townsend, KG Ewens, KK Naka, KK Roessler, KY Cha, L Barnard, L Cronin, L Cui, L Cui, L Gao, L Ibanez, L Ibanez, L Ibanez, L Manneras-Holm, L Moran, L Sterling, LJ Moran, LJ Moran, LJ Moran, LJ Moran, LJ Moran, LJ Moran, LJ Webber, LO Tso, M Api, M Eriksen, M Harris-Glocker, M Hudecova, M Kahsar-Miller, M Luque-Ramirez, M Luque-Ramirez, M Maliqueo, M Rajkhowa, M Wiksten-Almstromer, MA Sagle, MB Khomami, ME Gibson-Helm, MG Hayes, MH van Hooff, MJ Nahuis, MJ Solnik, ML Pan, ML Walls, MM Zain, MR Jones, N Cinar, N Cinar, N Lass, N Naderpoor, N Roos, NF Goodman, NK Stepto, NM Daan, NM O'Meara, O Koulouri, O Valkenburg, P Moghetti, PO Dale, Q Du, R Azziz, R Azziz, R Azziz, R Azziz, R Azziz, R Azziz, R Hart, R Homburg, R Khera, R Mathur, R Pasquali, R Saxena, R Shroff, RA DeFronzo, RC Christian, RJ Norman, RL Thomson, RN Bergman, Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, RS Legro, RS Legro, RS Legro, RS Legro, RS Legro, S Catteau-Jonard, S Elsenbruch, S Hahn, S Iftikhar, S Mahabeer, S Palomba, S Venturoli, S Wild, S Wild, S Zhao, SA Anderson, SA Stubbs, SE Recabarren, SM Veltman-Verhu lst, SS Lim, ST Bird, T Meas, T Sir-Petermann, T Sir-Petermann, T Tang, T Tang, Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, TP Ciaraldi, TP Ciaraldi, TP Ciaraldi, TP Ciaraldi, TY Chuang, U Ezeh, U Shim, V Padmanabhan, WT Garvey, X Cai, XJ Li, XZ Jia, Y Li, Y Shi, Y Shi, YH Chen, YV Louwers, YY Zhang, ZJ Chen   +230 more
core   +1 more source

Fasting plasma glucose performs better than glycated hemoglobin and glycated albumin for diagnosing gestational diabetes

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective Universal screening for gestational diabetes mellitus (GDM) using the oral glucose tolerance test (OGTT) has been recommended. In resource‐poor environments, OGTTs are only administered to high‐risk cases. In countries such as South Africa, where female obesity is common, this translates into high numbers of tests.
Lungile Khambule, Lawrence Chauke, Nigel J. Crowther, Jaya A. George   +3 more
wiley   +1 more source

Pharmacological sympathetic denervation prevents the development of polycystic ovarian syndrome in rats injected with estradiol valerate

Reproductive Biology and Endocrinology, 2018
Background The injection of estradiol valerate in female rats induces polycystic ovary syndrome, which is characterized by polycystic ovaries, anovulation, and hyperandrogenism.
Julieta A. Espinoza, Wendy Alvarado, Berenice Venegas, Roberto Domínguez, Leticia Morales-Ledesma   +4 more
doaj   +1 more source

Genome-wide association study identifies common and low-frequency variants at the AMHgene locus that strongly predict serum AMH levels in males [PDF]

, 2016
Anti-Müllerian hormone (AMH) is an essential messenger of sexual differentiation in the foetus and is an emerging biomarker of postnatal reproductive function in females.
Day, Felix R., Lawlor, Debbie A., McMahon, George, Nelson, Scott M., Perry, John R.B., Ring, Susan M.   +5 more
core   +1 more source